Evidence map›Paper›PMID 38695079›Full record

ArticleClinical and experimental immunology2024

Immune profiling reveals umbilical cord blood mononuclear cells from South India display an IL-8 dominant, CXCL-10 deficient polyfunctional monocyte response to pathogen-associated molecular patterns that is distinct from adult blood cells.

Vasista Adiga, Hima Bindhu, Asma Ahmed, Nirutha Chetan Kumar, Himanshu Tripathi, George D'Souza, Mary Dias, Sudarshan Shivalingaiah, Srishti Rao, Shanti K N and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Vasista AdigaHuman Immunology Laboratory, Division of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.
Hima BindhuHuman Immunology Laboratory, Division of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.
Asma AhmedHuman Immunology Laboratory, Division of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.
Nirutha Chetan KumarHuman Immunology Laboratory, Division of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.
Himanshu TripathiHuman Immunology Laboratory, Division of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.
George D'SouzaDepartment of Pulmonary Medicine, St. John's Medical College, Bangalore, India.
Mary DiasDivision of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.
Sudarshan ShivalingaiahDivision of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.
Srishti RaoDivision of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.
Shanti K NDepartment of Biotechnology, PES University, Bangalore, Karnataka, India.
Catherine HawrylowiczPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, Faculty of Life Science & Medicine, King's College, London, UK.
Pratibha DwarkanathDivision of Nutrition, St. John's Research Institute, Bangalore, Karnataka, India.
Annapurna VyakarnamHuman Immunology Laboratory, Division of Infectious Diseases, St. John's Research Institute, Bangalore, Karnataka, India.ORCID 0000-0003-4260-258X
St.John's Medical College Hospital · INKing's College London · GBPES University · INSt. John's National Academy of Health Sciences · IN

Funding

LC: HIV Vaccine Trials NetworkUM1AI068618 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Margaret Juliana McElrath · 2011 to 2026
$483.6M
DBT-Biotechnology Industry Research Assistance Council BT/COVID0073/02/20DBT-National Institutes of Health (NIH)Department of Biotechnology, Ministry of Science and Technology, India (DBT) BT/PR30219/MED/15/189/2018Felicity Wilde Charitable TrustNational Institute of Allergy and Infectious Diseases of the US National Institutes of Health UM1 AI 068618NIAID NIH HHS UM1 AI068618
6 · The paper itself

Abstract

Neonate responses to pathogen-associated molecular patterns (PAMPS) differ from adults; such understanding is poor in Indian neonates, despite recognized significant infectious risk. Immune profiling analysis was undertaken of 10 secreted mediators contextualized with cellular source induced by six PAMPs in umbilical cord (CB; n = 21) and adult-blood (PBMC; n = 14) from a tertiary care hospital in South India. Differential cytokine expression analysis (minimum log2-fold difference; adj P-value < 0.05) identified bacterial PAMPs induced higher concentrations of IL-1β, IL-10, TNF-α in adults versus IL-8, GM-CSF, IFN-γ, and IL-2 in CB. CB responded to poly I:C and SARS-CoV-2 lysate with a dominant IL-8 response, whereas in PBMC, CXCL-10 dominated poly I:C, but not SARS-CoV-2, responses, highlighting potential IL-8 importance, in the absence of Type I Interferons, in antiviral CB immunity. Candida albicans was the only PAMP to uniformly induce higher secretion of effectors in CB. The predominant source of IL-8/IL-6/TNF-α/IL-1β in both CB and PBMC was polyfunctional monocytes and IFN-γ/IL-2/IL-17 from innate lymphocytes. Correlation matrix analyses revealed IL-8 to be the most differentially regulated, correlating positively in CB versus negatively in PBMC with IL-6, GM-CSF, IFN-γ, IL-2, consistent with more negatively regulated cytokine modules in adults, potentially linked to higher anti-inflammatory IL-10. Cord and adult blood from India respond robustly to PAMPs with unique effector combinations. These data provide a strong foundation to monitor, explore, mechanisms that regulate such immunity during the life course, an area of significant global health importance given infection-related infant mortality incidence.

Indexed as

Chemokine CXCL10COVID-19Fetal BloodInterleukin-8Leukocytes, MononuclearMonocytesSARS-CoV-2AdultCandida albicansCytokinesFemaleHumansIndiaInfant, NewbornInterleukin-10MaleChemokine CXCL10CXCL10 protein, humanCXCL8 protein, humanCytokinesInterleukin-10Interleukin-8Poly I-Ccytokinesmonocytesneonatespathogen-associated molecular patternstoll-like receptors

Identifiers

PMID38695079
PMCPMC11310697
OpenAlexW4396586026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.